Should GLP-1’s be Covered by Medicare & Medicaid?

The Biden administration announcing Medicare and Medicaid coverage for medications such as Wegovy and Zepbound.

Transcript

00:00Millions of Americans could soon be eligible for insurance coverage for hugely popular

00:05GLP-1 weight loss drugs.

00:07The Biden administration announcing Medicare and Medicaid coverage for medications such

00:13as Wagovi and ZepBound, which can cost more than $1,000 a month.

00:19The proposed Health and Human Services rule could potentially cover 3.4 million Americans

00:24on Medicare and an additional 4 million covered by Medicaid.

00:28The high cost of GLP-1s has been a subject of discussion on Capitol Hill.

00:34The Novo Nordisk weight loss drug, Wagovi, costs more than $1,300 in the U.S. compared

00:41to just $140 in Germany and $92 in the U.K.